181 filings
Page 3 of 10
S-8
v24z0w266drza
27 Jun 23
Registration of securities for employees
8:19am
6-K
sy2jflofyo7gu2oe
8 Jun 23
Voting Rights and Shares Capital of the Company
4:15pm
6-K
88pree8n9nl1nqzr5xw
17 May 23
NANOBIOTIX Provides First Quarter 2023 Operational and Financial Update
4:15pm
6-K
r4d ojdh8b5hw4
5 May 23
Current report (foreign)
6:00am
6-K
c652qia3 sf7u8c3fcw0
24 Apr 23
NANOBIOTIX Provides Business Update and Reports Full Year 2022 Financial Results
7:55pm
6-K
se86spk s6
17 Apr 23
Current report (foreign)
4:18pm
6-K
4d6 0x45vt2g341nf
11 Apr 23
Voting Rights and Shares Capital of the Company
4:15pm
6-K
tqfdrgcnflg3249ya3na
27 Mar 23
Nanobiotix to Postpone Full Year 2022 Financial Results and Conference Call
4:15pm
6-K
33t1lnr
14 Mar 23
Current report (foreign)
4:15pm
6-K
k7rurdec
14 Feb 23
Voting Rights and Shares Capital of the Company
4:15pm
6-K
7dyv1f21
11 Jan 23
Voting Rights and Shares Capital of the Company
5:15pm
6-K
ej0f9wh6
27 Dec 22
Current report (foreign)
6:05am
6-K
04qktl9rid
21 Dec 22
NANOBIOTIX Announces Termination of Liquidity Contract and Publishes End of Contract Statement
4:15pm
6-K
g85j59
8 Dec 22
Voting Rights and Shares Capital of the Company
4:15pm
6-K
35qw7wqftbpu56eqq
15 Nov 22
NANOBIOTIX to Present at the 5th Annual Evercore ISI HealthCONx Conference
4:15pm
6-K
zz1gf
14 Nov 22
NANOBIOTIX Announces Recommended Phase 2 Dose for NBTXR3 in Pancreatic Cancer
4:17pm
6-K
e43brdalk
10 Nov 22
Current report (foreign)
6:00am
6-K
6ke380si1 f13wds
9 Nov 22
NANOBIOTIX Provides Third Quarter 2022 Operational and Financial Update
4:15pm
6-K
kzp4skano7k
8 Nov 22
NANOBIOTIX Voting Rights and Shares Capital of the Company
4:15pm